JP2019041696A - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP2019041696A JP2019041696A JP2017169515A JP2017169515A JP2019041696A JP 2019041696 A JP2019041696 A JP 2019041696A JP 2017169515 A JP2017169515 A JP 2017169515A JP 2017169515 A JP2017169515 A JP 2017169515A JP 2019041696 A JP2019041696 A JP 2019041696A
- Authority
- JP
- Japan
- Prior art keywords
- oral composition
- placenta extract
- decalactone
- collagen peptide
- linalool
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 102000008186 Collagen Human genes 0.000 claims abstract description 44
- 108010035532 Collagen Proteins 0.000 claims abstract description 44
- 229920001436 collagen Polymers 0.000 claims abstract description 44
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims abstract description 42
- 210000002826 placenta Anatomy 0.000 claims abstract description 39
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 33
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims abstract description 21
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims abstract description 21
- 229930007744 linalool Natural products 0.000 claims abstract description 21
- IFYYFLINQYPWGJ-VIFPVBQESA-N gamma-Decalactone Natural products CCCCCC[C@H]1CCC(=O)O1 IFYYFLINQYPWGJ-VIFPVBQESA-N 0.000 claims abstract description 19
- 235000013361 beverage Nutrition 0.000 abstract description 29
- 235000019640 taste Nutrition 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 description 31
- 235000019634 flavors Nutrition 0.000 description 30
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 11
- 230000000873 masking effect Effects 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 8
- 239000004365 Protease Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- -1 promeline Proteins 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000881711 Acipenser sturio Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
本発明は、プラセンタエキス及び/又はコラーゲンペプチドの有する独特のにおいや味をマスキングした、経口用組成物に関する。 The present invention relates to an oral composition in which the unique odor and taste of placenta extract and / or collagen peptide are masked.
プラセンタエキスは、美容、健康又は医薬関連分野において盛んに利用されている。例えば、プラセンタエキス、コラーゲン由来成分及びストレス緩和剤を含有することを特徴とする経口用組成物(特許文献1)、オリゴ糖とプラセンタエキスの組み合わせを特徴とする腸内環境改善組成物(特許文献2)、プラセンタエキスを含有する神経細胞活性化剤(特許文献3)、コラーゲン加水分解物、豚プラセンタエキス、ライチ由来の低分子化ポリフェノール及びアスコルビン酸類を美容成分として含有することを特徴とする健康食品(特許文献4)等が知られている。 Placenta extract is actively used in the fields of beauty, health or medicine. For example, an oral composition characterized by containing a placenta extract, a collagen-derived component and a stress relieving agent (Patent Document 1), an intestinal environment improving composition characterized by a combination of oligosaccharide and placenta extract (Patent Document) 2) A health comprising a nerve cell activator containing a placenta extract (Patent Document 3), a collagen hydrolyzate, a porcine placenta extract, a low molecular weight polyphenol derived from lychee, and ascorbic acids as cosmetic ingredients. Food (patent document 4) etc. are known.
しかしながら、プラセンタエキスは、その起源が生物であるため、経口で摂取する際、特有の不快な味や臭いを有しており、それらのマスキングが課題であった。 However, the placenta extract has a peculiar unpleasant taste and smell when taken orally because its origin is a living organism, and masking them has been a problem.
またコラーゲンペプチドは、動物や魚類から抽出されるコラーゲンやゼラチンを加水分解により低分子化したものであり、美容効果や関節強化効果が知られている。これまでにコラーゲンペプチドの前記効果を期待して、錠剤、顆粒剤、カプセル剤、散剤、飲料などに配合した数多くの製品が上市されている。 Collagen peptides are collagens and gelatins extracted from animals and fish that have been reduced in molecular weight by hydrolysis, and are known for their beauty effects and joint strengthening effects. In the past, many products formulated into tablets, granules, capsules, powders, beverages, etc. have been put on the market in anticipation of the above-mentioned effects of collagen peptides.
コラーゲンペプチドの効果を得るためには、コラーゲンペプチドを継続して摂取する必要があるが、そのためには容易に摂取できる飲料の形態が好ましい。しかし、コラーゲンペプチドを含む飲料には、嗅覚で感じる生臭みがあるという問題があった。また、低分子のコラーゲンペプチドを配合すると、不純物として含まれるアミノ酸に由来する苦味を呈する場合がある。 In order to obtain the effect of the collagen peptide, it is necessary to continuously ingest the collagen peptide. For this purpose, a drink form that can be easily ingested is preferable. However, there is a problem that beverages containing collagen peptides have a raw odor that is felt by smell. Moreover, when a low molecular weight collagen peptide is mix | blended, the bitter taste derived from the amino acid contained as an impurity may be exhibited.
このように不快臭を有するコラーゲンペプチドを含む飲料について、例えば、特許文献5には、コラーゲン加水分解物を含む多種の栄養素を含有する飲料において、ハトムギエキス等をふくむ2種以上のエキスや酸味剤、フルーツ系フレーバー等を用いることで風味が良好な健康飲料を実現する技術が開示されている。 Regarding beverages containing collagen peptides having an unpleasant odor in this way, for example, Patent Document 5 discloses beverages containing various nutrients including collagen hydrolysates, and two or more extracts and sour agents containing barley extract and the like. In addition, a technology for realizing a healthy beverage having a good flavor by using a fruit flavor or the like is disclosed.
また特許文献6には、魚由来コラーゲンペプチドを配合したゼリー飲料の魚臭を難消化性デキストリンを用いてマスキングすること、特許文献7にはコラーゲンペプチドを含有する飲食品の呈味を、スクラロース及びステビア抽出物を配合することにより改善することが開示されている。 Patent Document 6 describes masking the fish odor of a jelly drink containing a fish-derived collagen peptide using indigestible dextrin, and Patent Document 7 describes the taste of a food or drink containing a collagen peptide, sucralose and It is disclosed to improve by formulating stevia extract.
しかし従来の、コラーゲンペプチドを含有する飲食品の生臭みのマスキングについては十分ではなく、特に商品性の点で改善の余地があるものであった。 However, the conventional masking of the raw odor of foods and drinks containing collagen peptides is not sufficient, and there is room for improvement, particularly in terms of merchantability.
本願発明は、プラセンタエキス及び/又はコラーゲンペプチドの有する独特の臭いや味をマスキングした、プラセンタエキス及び/又はコラーゲンペプチド含有経口用組成物及びその製造方法を提供することを課題とする。 This invention makes it a subject to provide the placenta extract and / or collagen peptide containing oral composition which masked the unique smell and taste which a placenta extract and / or collagen peptide have, and its manufacturing method.
(1)
(A)〜(C)を含有する経口用組成物を提供する。
(A)プラセンタエキス及び/又はコラーゲンペプチド
(B)リナロール
(C)γ−デカラクトン
(1)
An oral composition containing (A) to (C) is provided.
(A) Placenta extract and / or collagen peptide (B) linalool (C) γ-decalactone
(2)
飲料であることを特徴とする請求項1に記載の、経口用組成物を提供する。
(2)
The oral composition according to claim 1, which is a beverage.
(3)
リナロールを0.1〜1.2ppm含有する請求項1又は請求項2に記載の、経口用組成物を提供する。
(3)
The oral composition according to claim 1 or claim 2 containing 0.1 to 1.2 ppm of linalool.
(4)
γ−デカラクトンを0.5〜10ppm含有する請求項1〜請求項3の1項に記載の、経口用組成物を提供する。
(4)
The oral composition according to claim 1, which contains 0.5 to 10 ppm of γ-decalactone.
本発明の経口用組成物は、リナロールとγ−デカラクトンを併用して用いることにより、プラセンタエキス及び/又はコラーゲンペプチドの有する独特の臭いや味をマスキングする効果を発揮する。 The oral composition of the present invention exhibits the effect of masking the unique odor and taste of the placenta extract and / or collagen peptide by using linalool and γ-decalactone in combination.
以下本発明を実施するための形態を説明する。 Hereinafter, modes for carrying out the present invention will be described.
本発明の経口用組成物は、プラセンタエキス及び/又はコラーゲンペプチドを含有する。 The oral composition of the present invention contains a placenta extract and / or a collagen peptide.
プラセンタエキスを得る胎盤の由来としては、特に起源を問わないが、ヒト、ウシ、ウマ、ブタ、ヒツジ、ヤギ、サケ、ニシン、チョウザメ、バラ、メロンなどが例示される。これらの起源の中でも、商用的な使用の観点から、ブタ由来のものを用いることが好ましい。また、既にプラセンタエキスとして市販されている商品があり、それを使用してもよい。 The origin of the placenta from which the placenta extract is obtained is not particularly limited, and examples thereof include humans, cows, horses, pigs, sheep, goats, salmon, herring, sturgeon, roses, and melons. Among these sources, it is preferable to use those derived from pigs from the viewpoint of commercial use. Moreover, there is a product already marketed as a placenta extract, and it may be used.
プラセンタエキスの製法の一例としては、ブタの胎盤を、プロテアーゼで処理する方法が挙げられる。当該プロテアーゼとしては、例えば、パパイン、トリプシン、ペプシン、プロメライン、サーモライシン等が挙げられる。これらの中ではパパインがプロテアーゼ処理の効率の点から好ましく用いられる。当該プロテアーゼ処理は、3〜75℃、0.5〜3時間程度反応させることにより進められ、前記プロテアーゼ処理により得られる成分を遠心分離、限外ろ過、珪藻土ろ過や、イオン交換樹脂、逆浸透ろ過、活性炭処理などにより精製することによりプラセンタエキスが得られる。 An example of a method for producing placenta extract is a method of treating pig placenta with a protease. Examples of the protease include papain, trypsin, pepsin, promeline, thermolysin and the like. Of these, papain is preferably used from the viewpoint of protease treatment efficiency. The protease treatment proceeds by reacting at about 3 to 75 ° C. for about 0.5 to 3 hours. The components obtained by the protease treatment are centrifuged, ultrafiltered, diatomaceous earth filtered, ion exchange resin, reverse osmosis filtered. The placenta extract can be obtained by purification by activated carbon treatment or the like.
上記のプラセンタエキスは、スプレードライ、凍結乾燥などの慣用の手段により粉末化することもできる。 The above placenta extract can be pulverized by conventional means such as spray drying and freeze drying.
プラセンタエキスの含有量は、1回あたりの摂取量として0.01〜20g、より好ましくは0.1〜10gである。0.01g未満の摂取ではプラセンタエキスの効果が発揮されない場合がある。また20gを超えて摂取しても、その効果に向上が認められない場合があり、非効率的である。 The content of the placenta extract is 0.01 to 20 g, more preferably 0.1 to 10 g as an intake amount per time. Ingestion of less than 0.01 g may not exhibit the effect of placenta extract. Moreover, even if it takes more than 20g, the effect may not be recognized, but it is inefficient.
本発明に用いるコラーゲンペプチドとは、動物の骨や皮に多く含まれるたんぱく質であるコラーゲンを加熱・変性させて得られるゼラチンや、それをさらに酸やアルカリあるいは酵素等で加水分解させたコラーゲンペプチドをいう。本発明においてコラーゲンは、由来生物(豚、牛、魚など)や製法(酸処理、アルカリ処理など)に関して特に限定されずに使用することができる。例えば動物としては、牛や豚、鶏などの動物の骨や皮、鮭、マグロ、ティラピア、タラ等の魚の皮、鱗を用いることができる。 The collagen peptide used in the present invention is gelatin obtained by heating and denaturing collagen, which is a protein that is abundant in animal bones and skins, and collagen peptide obtained by further hydrolyzing it with acid, alkali or enzyme. Say. In the present invention, collagen can be used without any particular limitation with respect to derived organisms (pigs, cows, fish, etc.) and production methods (acid treatment, alkali treatment, etc.). For example, as animals, bones and skins of animals such as cows, pigs and chickens, and fish skins and scales such as salmon, tuna, tilapia and cod can be used.
本発明に用いるコラーゲンペプチドの重量平均分子量は、100〜200000、好ましくは100〜5000、さらに好ましくは500〜5000、最も好ましくは1000〜4000の範囲にある。重量平均分子量20000を超えるコラーゲンペプチドの場合、原料に由来する臭いが強く、本発明の効果を発揮しない場合がある。平均分子量100未満のコラーゲンペプチドの場合、アミノ酸由来の味への影響が大きくなり、本発明の効果を発揮できない場合がある。 The weight average molecular weight of the collagen peptide used in the present invention is in the range of 100 to 200000, preferably 100 to 5000, more preferably 500 to 5000, and most preferably 1000 to 4000. In the case of a collagen peptide having a weight average molecular weight of more than 20000, the odor derived from the raw material is strong and the effects of the present invention may not be exhibited. In the case of a collagen peptide having an average molecular weight of less than 100, the influence on amino acid-derived taste is increased, and the effects of the present invention may not be exhibited.
本発明の経口用組成物におけるコラーゲンペプチドの配合量は、一回あたりの摂取量として、50mg〜10000mgが好ましい。50mg未満の配合では、コラーゲンを摂取する効果が見込まれにくい。 The compounding amount of the collagen peptide in the oral composition of the present invention is preferably 50 mg to 10000 mg as a single intake. If the formulation is less than 50 mg, the effect of ingesting collagen is unlikely to be expected.
本発明の経口用組成物には、リナロールとγ−デカラクトンを含有する。 The oral composition of the present invention contains linalool and γ-decalactone.
リナロールとγ−デカラクトンの経口用組成物への配合方法は、リナロール及びγ―デカラクトンそのものを配合しても、リナロール及び/又はγ−デカラクトンを含有する精油、フレーバーとして配合してもよい。 The method of blending linalool and γ-decalactone into the oral composition may be blended with linalool and γ-decalactone itself, or may be blended as an essential oil or flavor containing linalool and / or γ-decalactone.
リナロールを含有する精油としては、ローズウッド、リナロエ、芳樟、ネロリ、ラベンダー、ベルガモット、クラリセージ、コリアンダー等が例示される。これらの精油の中でも、臭いのマスキング効果の点からコリアンダーを用いることが最も好ましい。 Examples of essential oils containing linalool include rosewood, linaloe, mellow, neroli, lavender, bergamot, clarisage, coriander and the like. Among these essential oils, it is most preferable to use coriander from the viewpoint of odor masking effect.
またリナロールを含有するフレーバーとしては、ローズウッド様フレーバー、リナロエ様フレーバー、ネロリ様フレーバー、ラベンダー様フレーバー、ベルガモット様フレーバー、クラリセージ様フレーバー、コリアンダー様フレーバー等が例示される。これらの精油の中でも、臭いのマスキング効果の点からコリアンダー様フレーバーを用いることが最も好ましい。これらの精油の中でも、臭いのマスキング効果の点からコリアンダー様フレーバーを用いることが最も好ましい。 Examples of flavors containing linalool include rosewood-like flavors, linaloe-like flavors, neroli-like flavors, lavender-like flavors, bergamot-like flavors, clarisage-like flavors, and coriander-like flavors. Among these essential oils, it is most preferable to use a coriander-like flavor in terms of odor masking effect. Among these essential oils, it is most preferable to use a coriander-like flavor in terms of odor masking effect.
リナロールの経口用組成物への配合量としては、経口用組成物の剤型、プラセンタエキス及び/又はコラーゲンペプチドの配合量によって異なるが、好ましくは経口用組成物全量に対し、0.1〜1.2ppmとすることが好ましい。 The blending amount of linalool into the oral composition varies depending on the dosage form of the oral composition, the placenta extract and / or the collagen peptide, but preferably 0.1 to 1 with respect to the total amount of the oral composition. .2 ppm is preferred.
γ―デカラクトンを含有する精油としては、金木犀、ピーチ、スモモ、アプリコット、マンゴー等が例示される。これらの精油の中でも、臭いのマスキング効果の点からピーチマンゴーから選択される1種又は2種を用いることが最も好ましい。 Examples of the essential oil containing γ-decalactone include Kanagi cocoon, peach, plum, apricot, mango and the like. Among these essential oils, it is most preferable to use one or two selected from peach mango from the viewpoint of the odor masking effect.
またγ−デカラクトンを含有するフレーバーとしては、金木犀様フレーバー、ピーチ様フレーバー、マンゴー様フレーバー、スモモ様フレーバー、アプリコット様フレーバー等が例示される。これらの精油の中でも、臭いのマスキング効果の点からピーチ様フレーバー、マンゴー様フレーバーから選択される1種又は2種を用いることが最も好ましい。 Examples of flavors containing γ-decalactone include Kanagi-sama-like flavors, peach-like flavors, mango-like flavors, plum-like flavors, and apricot-like flavors. Among these essential oils, it is most preferable to use one or two kinds selected from a peach-like flavor and a mango-like flavor in terms of the odor masking effect.
γ−デカラクトンの経口用組成物への配合量としては、経口用組成物の剤型、プラセンタエキス及び/又はコラーゲンペプチドの配合量によって異なるが、好ましくは経口用組成物全量に対し、0.5〜10ppmとすることが好ましい。 The amount of γ-decalactone to be added to the oral composition varies depending on the dosage form of the oral composition, the amount of placenta extract and / or collagen peptide, but preferably 0.5% relative to the total amount of the oral composition. It is preferable to set it to -10 ppm.
本発明の経口用組成物は、その剤型を問わないが、プラセンタエキス及び/又はコラーゲンペプチドの味の感じやすさの点から、飲料、口腔崩壊錠、ガム、顆粒剤において良好な効果を発揮し、特に飲料の分野において有効である。なお、本発明において飲料とは、低粘度のいわゆるドリンク飲料のみならず、高粘度のゼリー剤を含む。 The oral composition of the present invention may be used in any dosage form, but exhibits good effects in beverages, orally disintegrating tablets, gums, and granules in terms of ease of taste of placenta extract and / or collagen peptide. In particular, it is effective in the field of beverages. In the present invention, the beverage includes not only a so-called drink beverage having a low viscosity but also a jelly agent having a high viscosity.
飲料の場合、pHは5以下、特にpHが2〜4に調整することが好ましい。 In the case of a beverage, it is preferable to adjust the pH to 5 or less, particularly to 2 to 4.
かかるpH調整剤としては、有機及び無機の食用酸を用いることができる。酸はそれらの非解離形で、あるいはそれらの各塩、例えばリン酸水素カリウム又はナトリウム、リン酸二水素カリウム又はナトリウム塩のような形態で用いてもよい。好ましい酸は、クエン酸、リンゴ酸、フマル酸、アジピン酸、リン酸、グルコン酸、酒石酸、フィチン酸、アスコルビン酸、酢酸、リン酸又はそれらの混合物を含めた食用酸が例示される。また、重炭酸塩類を用いることもできる。 As such a pH adjuster, organic and inorganic edible acids can be used. The acids may be used in their undissociated form or in the form of their respective salts, such as potassium or sodium hydrogen phosphate, potassium dihydrogen phosphate or sodium salt. Preferred acids are edible acids including citric acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, phytic acid, ascorbic acid, acetic acid, phosphoric acid or mixtures thereof. Bicarbonates can also be used.
この様にpHが調整された飲料として本発明にかかる経口用組成物を製造するには、同飲料は容器詰の形態で製造されることが好ましい。容器の種類に特に制限はないが、ポリエチレンテレフタレートを主成分とする成形容器(いわゆるPETボトル)、金属缶、金属箔やプラスチックフィルムと複合された紙容器、瓶など、いずれの容器も利用することができる。 In order to produce the oral composition according to the present invention as a beverage whose pH is adjusted in this way, the beverage is preferably produced in a container form. There are no particular restrictions on the type of container, but any container such as a molded container (so-called PET bottle) mainly composed of polyethylene terephthalate, a metal can, a paper container combined with a metal foil or plastic film, or a bottle should be used. Can do.
さらに、嗜好性を高めるために、適宜甘味料を選択して配合してもよい。例えば、ショ糖、ブドウ糖、麦芽糖等の炭水化物類、ステビア、アスパルテーム、ソーマチン、アセスルファムK等の高甘味度甘味料、ソルビトール、エリスリトール、キシリトール等の糖アルコール、グリセリン等のグリセロール類を利用することができる。 Furthermore, in order to improve palatability, you may select and mix | blend a sweetener suitably. For example, carbohydrates such as sucrose, glucose, and maltose, high-intensity sweeteners such as stevia, aspartame, thaumatin, and acesulfame K, sugar alcohols such as sorbitol, erythritol, and xylitol, and glycerols such as glycerin can be used. .
本発明の経口用組成物の調製に際しては、特別な界面活性剤等の添加物は必須ではないが、必要に応じて他の公知の添加剤、賦形剤その他を加えて適当な剤型へと加工してもよい。例えば液剤であれば、抗酸化剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤、pH調整剤などを混合して常法により、ドライシロップ剤、液剤などの経口物とすることができる。また固形剤であれば、賦形剤、崩壊剤、結合剤、滑沢剤、抗酸化剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤などを混合して常法により、顆粒剤、散剤、カプセル剤、錠剤などを製造することができる。 In the preparation of the oral composition of the present invention, special additives such as surfactants are not essential, but other known additives, excipients, etc. may be added to an appropriate dosage form as necessary. And may be processed. For example, in the case of a liquid agent, an antioxidant, a colorant, a flavoring agent, a surfactant, a plasticizer, a pH adjuster, etc. can be mixed to obtain an oral product such as a dry syrup agent or a liquid agent. If it is a solid agent, an excipient, a disintegrant, a binder, a lubricant, an antioxidant, a coating agent, a coloring agent, a corrigent, a surfactant, a plasticizer, etc. are mixed in a conventional manner. Granules, powders, capsules, tablets and the like can be produced.
抗酸化剤としては、例えばビタミンC、ジブチルヒドロキシトルエン(BHT)、没食子酸プロピル、ブチルヒドロキシアニソール(BHT)、α−トコフェロール、クエン酸などが挙げられる。 Examples of the antioxidant include vitamin C, dibutylhydroxytoluene (BHT), propyl gallate, butylhydroxyanisole (BHT), α-tocopherol, and citric acid.
着色剤としては、例えばカラメル、ベニバナ色素、シコン色素、ウコン色素、タール色素などが挙げられる。 Examples of the colorant include caramel, safflower dye, silicon dye, turmeric dye, and tar dye.
界面活性剤としては、例えばポリグリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンポリオキシプロピレンブロックコポリマー、ポリソルベート類、ラウリル硫酸ナトリウム、マクロゴール類、ショ糖脂肪酸エステルなどが挙げられる。 Examples of the surfactant include polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene polyoxypropylene block copolymer, polysorbate, sodium lauryl sulfate, macrogol, and sucrose fatty acid ester. It is done.
また、必要に応じてプラセンタエキス、コラーゲンペプチドの他に各種の生理活性成分を配合することもできる。係る生理活性成分としては、タンパク質及びその加水分解物、ペプチド、アミノ酸類、ビタミン類、多糖類、オリゴ糖、植物エキス、生薬等が挙げられる。 In addition to the placenta extract and collagen peptide, various physiologically active ingredients can be blended as necessary. Examples of such physiologically active ingredients include proteins and hydrolysates thereof, peptides, amino acids, vitamins, polysaccharides, oligosaccharides, plant extracts, crude drugs and the like.
また、本発明の経口用組成物に嗜好性を持たせるために、リナロール、γ−デカラクトン以外の各種香料等を添加しても良い。 In order to give palatability to the oral composition of the present invention, various fragrances other than linalool and γ-decalactone may be added.
以下、実施例により本発明を具体的に説明するが、これにより本発明の範囲が限定されるものではない。 EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the scope of the present invention is not limited thereby.
[香りの評価方法]
フレーバー評価専門パネリスト7名で、プラセンタの香りの強さについてブラインドでのVASを用いて評価を行った。
[Aroma evaluation method]
Seven panelists specializing in flavor evaluation evaluated the intensity of placenta fragrance using blind VAS.
[味覚の評価方法]
賞味期限評価などを行う分析型評価パネリスト7名で、プラセンタの味覚の強さについてブラインドでのVASを用いて評価を行った。
[Taste evaluation method]
Seven analyst-type evaluation panelists who perform expiry date evaluation etc. evaluated the strength of placenta taste using blind VAS.
表1に示した処方を用い、表2に記載したフレーバー所定量添加し定法により飲料を調製した。 Using the formulation shown in Table 1, a predetermined amount of flavor described in Table 2 was added, and a beverage was prepared by a conventional method.
[プラセンタエキス]
SPF豚(Specific Pathogen Free Pig)から得られた胎盤を除血、洗浄された精製組織を用い、酵素処理して得られたプラセンタ抽出エキスを、凍結乾燥し、1/9量のデキストリンに分散させたものをプラセンタエキスとして用いた。
[Placenta extract]
The placenta extract obtained by subjecting the placenta obtained from SPF pig (Specific Pathogen Free Pig) to blood removal and washing using purified tissue was freeze-dried and dispersed in 1/9 amount of dextrin. Was used as placenta extract.
[コラーゲンペプチド]
市販の重量平均分子量約3000の魚の皮及び鱗由来のコラーゲンペプチドを用いた。
[Collagen peptide]
A commercially available fish skin and scale-derived collagen peptide having a weight average molecular weight of about 3000 was used.
デカラクトンとリナロールを併用して配合した実施例1の飲料は、デカラクトン、リナロールをそれぞれ単体で配合した比較例3、比較例6の飲料と比較して、香り、味覚ともに相乗的にスコアが減少した。これに対し、デカラクトンとメントールを併用した比較例10の飲料は、それぞれ単独配合の比較例3、比較例4の飲料と比較して香りスコアの上昇が認められ、香り、味覚のバランスが崩れていた。 The beverage of Example 1 blended with decalactone and linalool was synergistically reduced in both aroma and taste compared to the beverages of Comparative Example 3 and Comparative Example 6 blended with decalactone and linalool, respectively. . In contrast, the beverage of Comparative Example 10 in which decalactone and menthol were used in combination showed an increase in the scent score as compared to the beverages of Comparative Example 3 and Comparative Example 4 each containing a single formulation, and the balance of fragrance and taste was lost. It was.
[実施例2] 飲料
(1)フレーバー混合物 110mg
(2)コラーゲン 550mg
(3)クエン酸 pHを3.5とする量
(4)甘味料 Brix値を7.0とする量
(5)精製水 全量を50mLとする量
フレーバー混合物は、飲料50mLとした場合、リナロール含有量が0.98ppm、γ−デカラクトン含有量が3.5ppmとなるフレーバーを用いた。
[Example 2] Beverages
(1) Flavor mixture 110mg
(2) Collagen 550mg
(3) Amount to make citric acid pH 3.5
(4) Sweetener Amount to make Brix value 7.0
(5) Purified water Amount to bring the total amount to 50 mL When the beverage mixture was 50 mL, a flavor having a linalool content of 0.98 ppm and a γ-decalactone content of 3.5 ppm was used.
[実施例3]
飲料
(1)フレーバー混合物 344mg
(2)プラセンタエキス 40mg
(3)コラーゲン 100mg
(4)クエン酸 pHを2.4とする量
(5)甘味料 Brix値を7.0とする量
(6)精製水 全量を140mLとする量
フレーバー混合物は、飲料140mLとした場合、リナロール含有量が0.14ppm、γ−デカラクトン含有量が4.25ppmとなるフレーバーを用いた。
[Example 3]
Beverage
(1) Flavor mixture 344mg
(2) Placenta extract 40mg
(3) Collagen 100mg
(4) Citric acid Amount to adjust pH to 2.4
(5) Sweetener Amount to bring Brix value to 7.0
(6) Purified water Amount to bring the total amount to 140 mL When the beverage mixture was 140 mL, a flavor having a linalool content of 0.14 ppm and a γ-decalactone content of 4.25 ppm was used.
[実施例4]
飲料
(1)フレーバー混合物 215mg
(2)プラセンタエキス 100mg
(3)コラーゲン 160mg
(4)クエン酸 pHを3.5とする量
(5)甘味料 Brix値を7.0とする量
(6)精製水 全量を100mLとする量
フレーバー混合物は、飲料100mLとした場合、リナロール含有量が0.74ppm、γ−デカラクトン含有量が3.5ppmとなるフレーバーを用いた。
[Example 4]
Beverage
(1) Flavor mixture 215mg
(2) Placenta extract 100mg
(3) Collagen 160mg
(4) Amount that makes citric acid pH 3.5
(5) Sweetener Amount to bring Brix value to 7.0
(6) Purified water Amount to make the total amount 100 mL When the beverage mixture was 100 mL, a flavor having a linalool content of 0.74 ppm and a γ-decalactone content of 3.5 ppm was used.
[実施例5]
飲料
(1)フレーバー混合物 215mg
(2)プラセンタエキス 100mg
(3)コラーゲン 160mg
(4)クエン酸 pHを3.5とする量
(5)甘味料 Brix値を7.0とする量
(6)精製水 全量を150mLとする量
フレーバー混合物は、飲料145mLとした場合、リナロール含有量が0.74ppm、γ−デカラクトン含有量が3.5ppmとなるフレーバーを用いた。
[Example 5]
Beverage
(1) Flavor mixture 215mg
(2) Placenta extract 100mg
(3) Collagen 160mg
(4) Amount that makes citric acid pH 3.5
(5) Sweetener Amount to bring Brix value to 7.0
(6) Purified water Amount to bring the total amount to 150 mL When the beverage mixture was 145 mL, a flavor having a linalool content of 0.74 ppm and a γ-decalactone content of 3.5 ppm was used.
実施例2〜5にかかる飲料は、プラセンタエキスやコラーゲンの生臭さが気にならない、良好な呈味の飲料であった。 The beverages according to Examples 2 to 5 were beverages having a good taste without being concerned about the raw smell of placenta extract or collagen.
Claims (4)
(A)プラセンタエキス及び/又はコラーゲンペプチド
(B)リナロール
(C)γ−デカラクトン An oral composition containing (A) to (C).
(A) Placenta extract and / or collagen peptide (B) linalool (C) γ-decalactone
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017169515A JP2019041696A (en) | 2017-09-04 | 2017-09-04 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017169515A JP2019041696A (en) | 2017-09-04 | 2017-09-04 | Oral composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2019041696A true JP2019041696A (en) | 2019-03-22 |
Family
ID=65812890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017169515A Withdrawn JP2019041696A (en) | 2017-09-04 | 2017-09-04 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2019041696A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023020776A (en) * | 2021-07-28 | 2023-02-09 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Food composition containing placenta extract and ginseng seed extract |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001333731A (en) * | 2000-05-25 | 2001-12-04 | Ichimaru Pharcos Co Ltd | Food having immunostimulation activity |
JP2005015686A (en) * | 2003-06-27 | 2005-01-20 | Kiyomitsu Kawasaki | Fruit-like flavor composition |
JP2009234980A (en) * | 2008-03-27 | 2009-10-15 | Japan Natural Laboratory Co Ltd | Cosmetic composition incorporating cell growth factor blended with neuraminic acids and placenta |
JP2010222287A (en) * | 2009-03-23 | 2010-10-07 | Lion Corp | Liquid composition for oral administration |
JP2013208095A (en) * | 2012-03-30 | 2013-10-10 | Kobayashi Pharmaceutical Co Ltd | Gelatin molding composition |
WO2015029605A1 (en) * | 2013-08-30 | 2015-03-05 | サントリーホールディングス株式会社 | Technique for suppressing odor of collagen peptide-containing drink |
JP2015063497A (en) * | 2013-09-26 | 2015-04-09 | 株式会社ノエビア | Oral composition |
CN104651202A (en) * | 2015-02-03 | 2015-05-27 | 马玲 | Cordyceps sinensis fruit milk vinegar for improving immunity |
JP2016138060A (en) * | 2015-01-28 | 2016-08-04 | 一丸ファルコス株式会社 | Glycoprotein substance including specific molecular binding unit in molecule, and use thereof |
-
2017
- 2017-09-04 JP JP2017169515A patent/JP2019041696A/en not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001333731A (en) * | 2000-05-25 | 2001-12-04 | Ichimaru Pharcos Co Ltd | Food having immunostimulation activity |
JP2005015686A (en) * | 2003-06-27 | 2005-01-20 | Kiyomitsu Kawasaki | Fruit-like flavor composition |
JP2009234980A (en) * | 2008-03-27 | 2009-10-15 | Japan Natural Laboratory Co Ltd | Cosmetic composition incorporating cell growth factor blended with neuraminic acids and placenta |
JP2010222287A (en) * | 2009-03-23 | 2010-10-07 | Lion Corp | Liquid composition for oral administration |
JP2013208095A (en) * | 2012-03-30 | 2013-10-10 | Kobayashi Pharmaceutical Co Ltd | Gelatin molding composition |
WO2015029605A1 (en) * | 2013-08-30 | 2015-03-05 | サントリーホールディングス株式会社 | Technique for suppressing odor of collagen peptide-containing drink |
JP2015063497A (en) * | 2013-09-26 | 2015-04-09 | 株式会社ノエビア | Oral composition |
JP2016138060A (en) * | 2015-01-28 | 2016-08-04 | 一丸ファルコス株式会社 | Glycoprotein substance including specific molecular binding unit in molecule, and use thereof |
CN104651202A (en) * | 2015-02-03 | 2015-05-27 | 马玲 | Cordyceps sinensis fruit milk vinegar for improving immunity |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023020776A (en) * | 2021-07-28 | 2023-02-09 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Food composition containing placenta extract and ginseng seed extract |
JP2023080197A (en) * | 2021-07-28 | 2023-06-08 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Food composition containing placenta extract and ginseng seed extract |
JP7297362B2 (en) | 2021-07-28 | 2023-06-26 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Food composition containing placenta extract and ginseng seed extract |
JP7687774B2 (en) | 2021-07-28 | 2025-06-03 | エルジー・エイチアンドエイチ・カンパニー・リミテッド | Food composition containing placenta extract and ginseng fruit extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5276813B2 (en) | Elastin-degrading peptide, method for producing elastin and its enzyme-degrading peptide | |
US20100105867A1 (en) | Process for producing osteocalcin-containing extract | |
WO2011108692A1 (en) | Agent for preventing muscular atrophy | |
EA021506B1 (en) | COMPOSITION FOR INCREASING Trp/LNAA RATIO IN BLOOD PLASMA AND PROCESS FOR PRODUCING SAME | |
JP2004238365A (en) | Skin beautifying agent, and beauty and health food | |
JP2009159983A (en) | Food composition | |
JP7554830B2 (en) | Oral composition, flavor improving method, chicken extract flavor improver, and use of type II collagen hydrolysate | |
JP2010030975A (en) | Bee larva solubilized product, preparation method thereof, and pharmaceutical product, cosmetic, or food and drink containing the bee larva solubilized product | |
JP5985456B2 (en) | Oral composition | |
JP2006273850A (en) | Suppression composition for lactic acid value elevation in blood, and food and drink comprising same | |
JP7082237B1 (en) | Beverages containing collagen and iron | |
JP4642321B2 (en) | Method for producing tryptophan-rich peptide | |
TWI377914B (en) | ||
ES2288791B1 (en) | PROCEDURE FOR OBTAINING A COLLAGEN HYDROLYZE. ENZYMATIC HYDROLYZE OF COLLAGEN OBTAINABLE BY THE PROCEDURE AND USES OF THE SAME. | |
WO2006115153A1 (en) | Food composition having skin condition-improving effect | |
JP2019041696A (en) | Oral composition | |
JP5355809B1 (en) | Beverage | |
JP6143218B2 (en) | Tendon and ligament function improving agent and pharmaceutical composition, food and feed containing the same | |
JP2019054769A (en) | Food for hair graying suppression | |
JP2016149946A (en) | Beverage | |
WO2008049942A1 (en) | Enzymatic collagen hydrolysate and method for obtaining same | |
JPWO2008146907A1 (en) | Oral composition | |
JP6506985B2 (en) | Beverage | |
JP2001026753A (en) | Composition for prophylaxis or treatment of hypertension | |
KR20190060256A (en) | A composition comprising peptide extracts of Yeonsan Ogye-egg and method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200316 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210127 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20210330 |